Loading…

Loading grant details…

Completed HORIZON European Commission

EpiGrid: Soft and flexible high density electrode grids for epilepsy surgery


Funder European Commission
Recipient Organization Universitair Medisch Centrum Utrecht
Country Netherlands
Start Date Mar 01, 2023
End Date Aug 31, 2024
Duration 549 days
Number of Grantees 3
Roles Participant; Coordinator
Data Source European Commission
Grant ID 101069176
Grant Description

Epilepsy is a highly prevalent brain disorder affecting 1% of the population. Brain surgery can cure epilepsy if we can delineate the diseased tissue intra-operatively. Unfortunately this delineation is currently not performed precisely and leads to poor success rates (50-70%).

High frequency oscillations (HFOs) have been identified as a biomarker of epileptogenic tissues, which can be electrically recorded with intraoperative electrocorticography.

These HFOs are specific of diseased epileptogenic brain tissues and remnance after an initial resection predicts continuation of seizures after surgery and thus may indicate incomplete removal.

The problem is that currently available electrode grids do not provide an adequate recording resolution (too low electrode density).

Moreover these electrodes are made of stiff materials, which yields low signal-to-noise level when recording from the cortical surface and which does not offer the possibility to record from within resection cavities, as the rigid electrodes cannot conform to the curvature of the cavity. We need high density flexible electrode grids that can adhere to the cortical surface and cavities.

Neurosoft Bioelectronics produces flexible and high density electrode grids based on unique stretchable soft electrodes.

Our goal is to use this grant to translate our clinical needs into an optimal design of soft electrode grids adapted for epilepsy surgery, with the help of an industrial designer.

We will first test these newly designed soft electrodes in vitro for clinical handability and improved signal quality, and eventually test them during epilepsy surgery in 12 patients. The recorded signals and clinical outcomes will be compared to those from standard rigid electrode grids.

Improved delineation of the epileptogenic tissue will lead to a higher succes rate, make epilepsy surgery a first choice treatment, and over all change this otherwise life-long disease into a curable disorder for many people.

All Grantees

Neurosoft Bioelectronics Sa; Universitair Medisch Centrum Utrecht; Souhoka Tessa

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant